Farley J. Abad

Array ( [id] => 4915195 [patent_doc_number] => 20080095795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Composition Comprising Iscom Particles And Live Micro-Organisms' [patent_app_type] => utility [patent_app_number] => 10/550026 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7965 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095795.pdf [firstpage_image] =>[orig_patent_app_number] => 10550026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 744347 [patent_doc_number] => 07026130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Binding protein' [patent_app_type] => utility [patent_app_number] => 10/804879 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 8394 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026130.pdf [firstpage_image] =>[orig_patent_app_number] => 10804879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5135930 [patent_doc_number] => 20070077559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Newcastle disease virus administration' [patent_app_type] => utility [patent_app_number] => 10/548057 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3131 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077559.pdf [firstpage_image] =>[orig_patent_app_number] => 10548057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655742 [patent_doc_number] => 20060141477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Use of parvovirus capsid particles in the inhibition of cell proliferation and migration' [patent_app_type] => utility [patent_app_number] => 10/792640 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17996 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141477.pdf [firstpage_image] =>[orig_patent_app_number] => 10792640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449815 [patent_doc_number] => 20040186273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Prion-binding ligands and methods of using same' [patent_app_type] => new [patent_app_number] => 10/791516 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12226 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186273.pdf [firstpage_image] =>[orig_patent_app_number] => 10791516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7422431 [patent_doc_number] => 20040229298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Methods and compositions for treating cervical cancer' [patent_app_type] => new [patent_app_number] => 10/789102 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 54149 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229298.pdf [firstpage_image] =>[orig_patent_app_number] => 10789102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256294 [patent_doc_number] => 20050075484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Construction and use of synthetic constructs encoding syndecan' [patent_app_type] => utility [patent_app_number] => 10/776989 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 34763 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075484.pdf [firstpage_image] =>[orig_patent_app_number] => 10776989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13382 [patent_doc_number] => 07807455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Method to confer cell culture replication activity to different Hepatitis C virus isolates' [patent_app_type] => utility [patent_app_number] => 10/543633 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7939 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807455.pdf [firstpage_image] =>[orig_patent_app_number] => 10543633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334915 [patent_doc_number] => 20040132132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method for identifying biologically active structures of microbial pathogens' [patent_app_type] => new [patent_app_number] => 10/468591 [patent_app_country] => US [patent_app_date] => 2004-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12278 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132132.pdf [firstpage_image] =>[orig_patent_app_number] => 10468591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105784 [patent_doc_number] => 20050107591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Cysteine variants of erythropoietin' [patent_app_type] => utility [patent_app_number] => 10/773530 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26771 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107591.pdf [firstpage_image] =>[orig_patent_app_number] => 10773530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097247 [patent_doc_number] => 20050129705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Modified HCV peptide vaccines' [patent_app_type] => utility [patent_app_number] => 10/770117 [patent_app_country] => US [patent_app_date] => 2004-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17863 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129705.pdf [firstpage_image] =>[orig_patent_app_number] => 10770117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056585 [patent_doc_number] => 06855809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Methods for the simultaneous detection of HCV antigens and HCV antibodies' [patent_app_type] => utility [patent_app_number] => 10/753910 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20336 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855809.pdf [firstpage_image] =>[orig_patent_app_number] => 10753910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325931 [patent_doc_number] => 20040138418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Epstein Barr virus induced genes' [patent_app_type] => new [patent_app_number] => 10/749990 [patent_app_country] => US [patent_app_date] => 2003-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16378 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138418.pdf [firstpage_image] =>[orig_patent_app_number] => 10749990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7177698 [patent_doc_number] => 20050123901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Method and device for the rapid clinical diagnosis of hepatitis C virus (HCV) infection in biological samples' [patent_app_type] => utility [patent_app_number] => 10/744375 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3520 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123901.pdf [firstpage_image] =>[orig_patent_app_number] => 10744375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5800014 [patent_doc_number] => 20060035212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Molecules inhibiting hepatitis c virus protein synthesis and method for screening same' [patent_app_type] => utility [patent_app_number] => 10/538471 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7663 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035212.pdf [firstpage_image] =>[orig_patent_app_number] => 10538471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7673357 [patent_doc_number] => 20040180422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Methods and compositions for controlling valency of phage display' [patent_app_type] => new [patent_app_number] => 10/723981 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27416 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180422.pdf [firstpage_image] =>[orig_patent_app_number] => 10723981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674720 [patent_doc_number] => 20040127398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Long lasting synthetic glucagon like peptide (GLP-1)' [patent_app_type] => new [patent_app_number] => 10/722733 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20427 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127398.pdf [firstpage_image] =>[orig_patent_app_number] => 10722733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199665 [patent_doc_number] => 20040086535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Novel antiviral acitivities of primate theta defensins and mammalian cathelicidins' [patent_app_type] => new [patent_app_number] => 10/721839 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17039 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086535.pdf [firstpage_image] =>[orig_patent_app_number] => 10721839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905162 [patent_doc_number] => 20050100557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences' [patent_app_type] => utility [patent_app_number] => 10/722000 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 74453 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100557.pdf [firstpage_image] =>[orig_patent_app_number] => 10722000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325023 [patent_doc_number] => 20040138100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Long lasting synthetic glucagon like peptide (GLP-1)' [patent_app_type] => new [patent_app_number] => 10/723099 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20428 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138100.pdf [firstpage_image] =>[orig_patent_app_number] => 10723099 [rel_patent_id] =>[rel_patent_doc_number] =>)